Jump to main content
Jump to site search

Issue 8, 2017
Previous Article Next Article

Recent advances in nanomedicines for the treatment of rheumatoid arthritis

Author affiliations

Abstract

Rheumatoid arthritis (RA) is a severe systemic inflammatory disease. It is often associated with serious cartilage destruction and massive inflammatory infiltration, which might ultimately cause disability, wide complications and reduced life quality. Current clinical treatments of RA show several drawbacks such as high doses, frequent administration and serious side effects. These limitations have motivated tremendous expansion of the research and application of nanomedicines in RA therapy. In this review, we summarize the cutting edge progress in nanomedicines for the treatment of RA and discuss the application of various targeting strategies. Additionally, we also discuss the pivotal challenges to be addressed, as well as future perspectives.

Graphical abstract: Recent advances in nanomedicines for the treatment of rheumatoid arthritis

Back to tab navigation

Publication details

The article was received on 27 Mar 2017, accepted on 31 May 2017 and first published on 31 May 2017


Article type: Review Article
DOI: 10.1039/C7BM00254H
Citation: Biomater. Sci., 2017,5, 1407-1420
  •   Request permissions

    Recent advances in nanomedicines for the treatment of rheumatoid arthritis

    Q. Wang and X. Sun, Biomater. Sci., 2017, 5, 1407
    DOI: 10.1039/C7BM00254H

Search articles by author

Spotlight

Advertisements